How Quitting Smoking Can Quickly Lower Risk Of A-Fib
Smokers who make the decision to quit will experience immediate health benefits, including a rapid reduction in their risk of atrial fibrillation (A-Fib), according to new research published in JACC: Clinical Electrophysiology. The study, conducted by Dr. Gregory Marcus, a cardiologist at the University of California, San Francisco, offers compelling evidence for smokers to quit, showing that it’s never too late to avoid the damaging effects of smoking on heart health.
Dr. Marcus, the senior author of the study, emphasized that A-Fib can be prevented even in individuals who have smoked for years. "The findings provide a compelling new reason to show current smokers that it’s not too late to quit, and that having smoked in the past doesn’t mean you’re ‘destined’ to develop A-Fib," Marcus explained. "Even for the current and longtime smoker, A-Fib can still be avoided."
"There’s strong evidence that smoking increases the risk of A-Fib," Marcus said. "But the benefits of quitting smoking have been less certain." With this in mind, his team sought to determine whether quitting could significantly lower a person’s risk of developing A-Fib, or if the risk would remain the same.
The research team analyzed data from over 146,700 current and former smokers, tracking their smoking habits and health over a 12-year period using data from the UK Biobank database. The results were promising: former smokers had a 13% lower risk of developing A-Fib compared to current smokers, while those who quit during the study saw an 18% reduction in their risk.
"This is likely a testament to the potency of reducing atrial fibrillation risk pretty shortly after quitting," Marcus said in a statement from the American College of Cardiology.
The findings highlight the importance of quitting smoking, not only for general health but specifically for reducing the risk of serious heart conditions like A-Fib.
Quitting smoking is one of the most effective ways to lower the risk of A-Fib and improve overall heart health. While it can be challenging, the benefits of quitting are clear and immediate. Here are some tips to help you quit smoking successfully:
1. Choose a specific date to quit smoking and stick to it. Prepare yourself mentally and physically for this change.
2. Reach out to family, friends, or a support group to help keep you accountable. Sharing your goals with others can provide encouragement.
3. Options like nicotine patches, gum, or lozenges can help ease withdrawal symptoms and reduce cravings.
4. Identify situations that make you want to smoke, such as stress or social gatherings, and find healthy ways to cope with them.
5. Regular exercise can help distract you from cravings and improve your mood during the quitting process.
6. Drinking water can help flush nicotine out of your system faster, reducing cravings.
7. Activities like yoga, meditation, or deep breathing exercises can help manage stress, a common trigger for smoking.
Quitting smoking offers immediate and significant benefits, particularly in reducing the risk of atrial fibrillation. The latest research provides smokers with more motivation to quit, showing that it's never too late to take control of their heart health.
Credit: iStock
For decades, people have been advised to avoid full-fat dairy over concerns that it could contribute to weight gain and higher cholesterol levels. Now, a new, albeit small, study challenges that view. It found that three daily servings of full-fat dairy did not worsen weight or cholesterol and may even offer some health benefits.
The study, led by researchers at the University of Toronto, found that adults who consumed three servings of full-fat dairy each day did not experience adverse changes in blood cholesterol, blood lipids or insulin resistance. The findings were published in The Journal of Nutrition.
"Those that had three servings of dairy didn't have adverse levels of blood cholesterol or lipids or evidence of insulin resistance," said Professor Harvey Anderson of the University of Toronto.
Dairy foods contain saturated fat, which has traditionally been associated with higher cholesterol and an increased risk of cardiovascular disease.
As a result, dietary recommendations in Canada and many other countries have generally encouraged people to choose fat-free or low-fat dairy products to reduce saturated fat intake.
However, Anderson, a professor of nutritional sciences at the University of Toronto's Temerty Faculty of Medicine, said human research has not always supported these concerns.
Numerous human studies have found no link between full-fat dairy consumption and harmful health outcomes.
To examine the link, the 12-week study included 74 adults with overweight or obesity who were randomly assigned to one of three dietary groups:
After 12 weeks, researchers found no meaningful differences in weight gain, body composition or cholesterol levels between people following the low-dairy diet and those consuming three servings of dairy each day.
On the other hand, people consuming more dairy showed improvements in blood pressure and consumed more calcium, protein, and vitamin D.
The reason may be the "dairy matrix hypothesis," the researchers said. This suggests that the health effects of a food may depend on how its components interact rather than simply on the amount of one nutrient it contains.
"With dairy products, it's got two proteins -- casein and whey -- that are bound together with fat and with nutrients mixed in," Anderson said.
According to Anderson, this complex structure allows nutrients in dairy foods to be delivered to the body gradually. That may help explain why the effects of eating dairy can differ from what would be predicted by looking at saturated fat or other individual nutrients in isolation.
Anderson said the findings may be particularly relevant for older adults. As people age, they generally require less energy and may struggle to consume enough protein and other essential nutrients while maintaining an appropriate calorie intake.
Dairy is already a familiar food for many older adults and provides energy, protein and other nutrients. Anderson said it could therefore offer a practical way to help meet nutritional needs without increasing the risk of diabetes or other chronic diseases.
More broadly, the findings support an approach to nutrition research and dietary guidance that considers whole foods rather than focusing primarily on individual nutrients.
With nutrition trends constantly changing and dietary advice sometimes appearing contradictory, Anderson offered a simple message: "Keep it simple, eat a variety of foods and not too much of anything."
Credit: Instagram
Bruce Willis’ wife, Emma Heming Willis, has opened up about “wrestling” with guilt over celebrating her 50th birthday while her husband continues to battle dementia.
The former model turned 50 in June and, in an Instagram post, wrote, “I’m ready for this new decade and all it has to offer.”
However, she admitted she was initially wary of celebrating because of her husband’s dementia struggles. At the behest of friends and family, she decided to mark the milestone. Still, she said she continued to wrestle with guilt about celebrating while Bruce Willis is living with a terminal condition.
Speaking on a podcast, Emma said she had not been “in the celebratory feelings” recently and was unsure whether she wanted to do anything for her 50th birthday.
A friend encouraged her to celebrate, reminding her that she did not want to miss marking the milestone.
“I always wrestle with it, you know?” she said. “I think guilt is something that I am always carrying, but I’ve learned that it is really not helpful. What I know is I always go back to what would my husband want for me?”
She explained that even ordinary moments of celebration can bring guilt, as she often feels there are other things she should be doing for her husband.
“There are moments [when] you want to do something, [but] you say, ‘Oh, but I can’t, I can’t. There’s a million other things that I need to be doing for him.’”
However, Emma said she believes the Die Hard star would want her to enjoy the milestone with the people she loves. She said he “would want me to have a big fun bash” and “would want me to celebrate my life with my friends and family.”
In March 2023, Bruce Willis, who dominated Hollywood during his career, was diagnosed with frontotemporal dementia (FTD), a degenerative condition that can affect communication, behavior and motor skills.
This is not the first time Emma has spoken about the guilt and emotional challenges of caring for her husband.
Emma, who has been his primary caregiver, previously said that Bruce is supported, loved and cared for by the family.
“You know, we’re doing well. My husband is supported and loved and we’re doing the best we can under the circumstances,” she said during an interview on Today in May.
Last year, at the Women’s Alzheimer’s Movement Forum in Las Vegas, Emma also spoke about the emotional impact of Bruce’s diagnosis and the unseen toll of caregiving. She recalled the day Bruce was formally diagnosed as one that left her feeling “lost, isolated and afraid.”
Caregiving is a respectable position, but it's also a challenging and thankless one. For those who are caring for loved ones with dementia or other chronic illnesses, the stress of "keeping it all together" can result in a condition called caregiver burnout.
"Caring for someone is the most intimate and demanding work of love," Emma explained, "but when you're not noticed or supported, it begins to undermine your health—mentally and physically."
Credit: AI
Canada has never reported a case of Ebola, yet Nova Scotia has become one of the first places in the world where humans are receiving an experimental vaccine against the deadly virus.
The first participant received Moderna’s experimental mRNA-1469 vaccine in Truro, Nova Scotia, on August 3. The Phase 1 trial is being conducted at three Canadian sites in Truro, Halifax and Toronto and aims to enrol around 80 healthy adults.
The current outbreak in the Democratic Republic of Congo (DRC) is being caused by Bundibugyo ebolavirus, a relatively rare Ebola species for which there is currently no approved vaccine or treatment.
More than 3,800 infections and over 1,700 deaths have been reported in the outbreak, making it the second-largest Ebola outbreak on record.
Existing Ebola vaccines are largely designed to protect against the Zaire species, which caused previous major outbreaks. They cannot simply protect the masses against Bundibugyo.
This has created a dangerous situation: an outbreak is already underway, but scientists do not yet have a licensed vaccine specifically targeting the strain driving it.
Also read: Ebola Outbreak: Moderna Begins First Human Trial Of Bundibugyo Vaccine As Cases Rise to 3,748
Nova Scotia was not selected because Ebola is circulating there. In fact, Health Canada says there have been no cases of Ebola disease in Canada.
But, the province has something far more useful for an early vaccine trial: years of experience conducting vaccine research.
The Canadian Center for Vaccinology, a collaboration involving Dalhousie University, IWK Health and Nova Scotia Health, has extensive experience in vaccine development and clinical trials.
Moderna said Canada was selected because of its experience with early-stage clinical trials, Health Canada's regulations and the country's long history of contribution to research on filoviruses, the family of viruses that includes Ebola.
“Canadian researchers and participants are contributing an important first step in a broader international effort to develop a vaccine against a form of Ebola for which no approved protection is currently available,” Hamilton Bennett, Moderna's executive director of global health security and R&D partnerships, said.
Phase 1 trials primarily examine whether a vaccine is safe, what dose should be used and whether it produces an immune response.
Participants are given the vaccine, not the Ebola virus, and they cannot get Ebola from the vaccine trial itself.
The mRNA-1469 vaccine uses the same mRNA technology that Moderna used for its COVID-19 vaccine. It is designed to teach the immune system to recognise Bundibugyo virus and produce an immune response without exposing volunteers to the live virus.
The Coalition for Epidemic Preparedness Innovations (CEPI) has committed up to US$50 million to support Moderna's vaccine development. If the vaccine eventually proves successful, Moderna has committed to making at least 500,000 doses available to low- and middle-income countries.
Dalhousie researchers are studying the Bundibugyo virus itself. Recent work helped identify a genetically distinct variant circulating in the DRC and investigate possible treatment options.
Phase 1 of the trial can establish safety and immune responses, but larger Phase 2 and Phase 3 studies will be needed to determine whether the vaccine actually prevents Ebola disease.
© 2024 Bennett, Coleman & Company Limited